This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House
XenoPort Inc
XNPT : NASDAQ : Health Care
$6.40 0.10 | 1.59%
Today's Range: 6.27 - 6.43
Avg. Daily Volume: 354,400
10/23/14 - 11:11 AM ET

PEER GROUP: Pharmaceuticals



Ticker Company Name Recent
Price($)
Market
Cap($M)
Price/
Earnings
Net Sales
TTM($M)
Net Income
TTM($M)
XNPT XENOPORT INC 6.41 398.78 n/m 14.12 313.80
TXMD THERAPEUTICSMD INC 3.98 620.12 n/m 11.74 99.15
TTPH TETRAPHASE PHARMACEUTICALS 20.11 523.20 n/m 7.80 21.39
OMER OMEROS CORP 13.78 468.46 n/m 0.51 -87.96
FLML FLAMEL TECHNOLOGIES SA -ADR 12.07 465.67 n/m 29.02 24.06
CEMP CEMPRA INC 12.66 420.86 n/m 8.23 80.05
SCLN SCICLONE PHARMACEUTICALS INC 7.78 397.40 18.52 127.04 -4.44
PETX ARATANA THERAPEUTICS 11.34 384.96 n/m 0.60 n/a
VVUS VIVUS INC 3.60 372.46 n/m 130.01 1015.18
PTX PERNIX THERAPEUTICS HOLDINGS 9.59 364.84 n/m 78.66 -0.42
SUPN SUPERNUS PHARMACEUTICALS INC 8.39 360.11 n/m 50.35 3029.08
The peer group comparison is based on Major Pharmaceuticals companies of comparable size.

Price Earnings Comparison

XNPT Ind Avg S&P 500
n/m 38.74 18.06
 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades


Top Rated Stocks Top Rated Funds Top Rated ETFs